Published mark
Medtronic
Medtronic plc
NYSE: MDT. Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:b7caa2bc-5395-4be8-b64b-637e20f56cc0
- SEC CIK
- 0001613103
- Website
- www.medtronic.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Geoffrey S. MarthaSince Jun 20, 2025
- Chair
- Not published
- Independent
- 11 / 1212 directors published
- Published claims
- 617 distinct sources
- Evidence records
- 130 pinned
- Source conflicts
- 0None open
Built from 7 distinct sources and 13 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Brett Wall executive of Medtronic, effective 2025-06-20.
EffectiveEffective Jun 20, 2025E4
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and President, Neuroscience Portfolio | Brett Wall | Jun 2025 | current | Source reportedE4 |
| Chairman and Chief Executive Officer | Geoffrey S. Martha | Jun 2025 | current | Source reportedE5 |
| Executive Vice President, Enterprise Operations | Gregory L. Smith | Jun 2025 | current | Source reportedE6 |
| Executive Vice President, General Counsel and Secretary | Ivan K. Fong | Jun 2025 | current | Source reportedE7 |
| Senior Vice President, Chief Human Resources Officer | Matthew Walter | Jun 2025 | current | Source reportedE8 |
| Executive Vice President and President, Medical Surgical Portfolio and Americas | Michael Marinaro | Jun 2025 | current | Source reportedE9 |
| Executive Vice President and President, Cardiovascular Portfolio | Skip Kiil | Jun 2025 | current | Source reportedE10 |
| Executive Vice President and Chief Financial Officer | Thierry Pi ton | Not captured | unknown | Source reportedE11 |
Board of directors
Evidence12 directors published. 11 of 12 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Craig Arnold | Independent | 2015 | GrowthGrowth; Nominating and Corporate Governance · ChairNominating and Corporate Governance, chair | Source reportedE3 |
| Elizabeth G. Nabel | Independent | 2014 | Compensation and Talent, chairCompensation and Talent · Chair; GrowthGrowth | Source reportedE3 |
| Geoffrey S. Martha | Not independent | 2019 | GrowthGrowth; OperationsOperations | Source reportedE3 |
| Gregory P. Lewis | Independent | 2023 | Audit, chairAudit · Chair; GrowthGrowth | Source reportedE3 |
| John P. Groetelaars | Independent | 2025 | GrowthGrowth; Nominating and Corporate GovernanceNominating and Corporate Governance | Source reportedE3 |
| Joon S. Lee | Independent | 2025 | Compensation and TalentCompensation and Talent; QualityQuality | Source reportedE3 |
| Kendall J. Powell | Independent | 2007 | Compensation and TalentCompensation and Talent; QualityQuality | Source reportedE3 |
| Kevin E. Lofton | Independent | 2020 | Compensation and TalentCompensation and Talent; QualityQuality | Source reportedE3 |
| Lidia L. Fonseca | Independent | 2022 | AuditAudit; Operations; Nominating and Corporate GovernanceNominating and Corporate GovernanceOperations | Source reportedE3 |
| Randall J. Hogan, III | Independent | 2015 | AuditAudit; OperationsOperations | Source reportedE3 |
| Shaun Donnelly | Independent | 2013 | AuditAudit; OperationsOperations | Source reportedE3 |
| William R. Jellison | Independent | 2025 | GrowthGrowth; OperationsOperations | Source reportedE3 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Gregory P. Lewis | Gregory P. Lewis, Lidia L. Fonseca, Randall J. Hogan, III, Shaun Donnelly | Not described in the published record |
| Audit · Chair; Growth | Not published | Gregory P. Lewis | Not described in the published record |
| Audit; Operations | Not published | Randall J. Hogan, III, Shaun Donnelly | operational |
| Audit; Operations; Nominating and Corporate Governance | Not published | Lidia L. Fonseca | operational |
| Compensation and Talent | Elizabeth G. Nabel | Elizabeth G. Nabel, Joon S. Lee, Kendall J. Powell, Kevin E. Lofton | human_capital |
| Compensation and Talent · Chair; Growth | Not published | Elizabeth G. Nabel | human_capital |
| Compensation and Talent; Quality | Not published | Joon S. Lee, Kendall J. Powell, Kevin E. Lofton | human_capital |
| Growth | Not published | Craig Arnold, Elizabeth G. Nabel, Geoffrey S. Martha, Gregory P. Lewis, John P. Groetelaars, William R. Jellison | Not described in the published record |
| Growth; Nominating and Corporate Governance | Not published | John P. Groetelaars | Not described in the published record |
| Growth; Nominating and Corporate Governance · Chair | Not published | Craig Arnold | Not described in the published record |
| Growth; Operations | Not published | Geoffrey S. Martha, William R. Jellison | operational |
| Nominating and Corporate Governance | Craig Arnold | Craig Arnold, John P. Groetelaars, Lidia L. Fonseca | Not described in the published record |
| Operations | Not published | Geoffrey S. Martha, Lidia L. Fonseca, Randall J. Hogan, III, Shaun Donnelly, William R. Jellison | operational |
| Quality | Not published | Joon S. Lee, Kendall J. Powell, Kevin E. Lofton | Not described in the published record |
Committee RecordAudit: Chair Gregory P. Lewis; Members Gregory P. Lewis (Chair); Lidia L. Fonseca; Randall J. Hogan, III; Shaun Donnelly
Committee AppointmentGregory P. Lewis: chair, Audit
Committee AppointmentLidia L. Fonseca: member, Audit
Committee AppointmentRandall J. Hogan, III: member, Audit
Committee AppointmentShaun Donnelly: member, Audit
Committee RecordCompensation and Talent: Chair Elizabeth G. Nabel; Members Elizabeth G. Nabel (Chair); Joon S. Lee; Kendall J. Powell; Kevin E. Lofton
Committee AppointmentElizabeth G. Nabel: chair, Compensation and Talent
Committee AppointmentJoon S. Lee: member, Compensation and Talent
Committee AppointmentKendall J. Powell: member, Compensation and Talent
Committee AppointmentKevin E. Lofton: member, Compensation and Talent
Committee RecordGrowth: Chair not stated; Members Craig Arnold; Elizabeth G. Nabel; Geoffrey S. Martha; Gregory P. Lewis; John P. Groetelaars; William R. Jellison
Committee AppointmentCraig Arnold: member, Growth
Committee AppointmentElizabeth G. Nabel: member, Growth
Committee AppointmentGeoffrey S. Martha: member, Growth
Committee AppointmentGregory P. Lewis: member, Growth
Committee AppointmentJohn P. Groetelaars: member, Growth
Committee AppointmentWilliam R. Jellison: member, Growth
Committee RecordNominating and Corporate Governance: Chair Craig Arnold; Members Craig Arnold (Chair); John P. Groetelaars; Lidia L. Fonseca
Committee AppointmentCraig Arnold: chair, Nominating and Corporate Governance
Committee AppointmentJohn P. Groetelaars: member, Nominating and Corporate Governance
Committee AppointmentLidia L. Fonseca: member, Nominating and Corporate Governance
Committee RecordOperations: Chair not stated; Members Geoffrey S. Martha; Lidia L. Fonseca; Randall J. Hogan, III; Shaun Donnelly; William R. Jellison
Committee AppointmentGeoffrey S. Martha: member, Operations
Committee AppointmentLidia L. Fonseca: member, Operations
Committee AppointmentRandall J. Hogan, III: member, Operations
Committee AppointmentShaun Donnelly: member, Operations
Committee AppointmentWilliam R. Jellison: member, Operations
Committee RecordQuality: Chair not stated; Members Joon S. Lee; Kendall J. Powell; Kevin E. Lofton
Committee AppointmentJoon S. Lee: member, Quality
Committee AppointmentKendall J. Powell: member, Quality
Committee AppointmentKevin E. Lofton: member, Quality
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerGeoffrey S. Martha, Chairman and Chief Executive Officer, from Jun 20, 2025
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingMDT (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 15, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: MDT | current | Oct 31, 1986 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameMedtronic plc
Entity StatusPublic listing published
Official Websitehttps://www.medtronic.com
Published FactUS
Published FactIreland
Published FactHealthcare
Published FactMedical - Devices
Published Facthttps://www.medtronic.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Brett WallExecutive Vice President and President, Neuroscience Portfoliocompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:22
- Geoffrey S. MarthaChairman and Chief Executive Officercompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:23
- Gregory L. SmithExecutive Vice President, Enterprise Operationscompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:24
- Ivan K. FongExecutive Vice President, General Counsel and Secretarycompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:25
- Matthew WalterSenior Vice President, Chief Human Resources Officercompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:26
- Michael MarinaroExecutive Vice President and President, Medical Surgical Portfolio and Americascompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:27
- Skip KiilExecutive Vice President and President, Cardiovascular Portfoliocompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:28
- Thierry Pi tonExecutive Vice President and Chief Financial Officercompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:29
- Craig ArnoldDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:10
- Elizabeth G. NabelDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:11
- Geoffrey S. MarthaDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:12
- Gregory P. LewisDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:13
- John P. GroetelaarsDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:14
- Joon S. LeeDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:15
- Kendall J. PowellDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:16
- Kevin E. LoftonDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:17
- Lidia L. FonsecaDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:18
- Randall J. Hogan, IIIDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:19
- Shaun DonnellyDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:20
- William R. JellisonDirectorcompany:b7caa2bc-5395-4be8-b64b-637e20f56cc0:leadership_role:21
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 13 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 7 Claims.
- E2Medtronic plc Form 10-K (filed 2026-06-18). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec proxy. Published Aug 25, 2025. Retrieved Mar 25, 2026. Cited by 12 Claims.
- E4sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E5sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E6sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E7sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E8sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E9sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E10sec filing. Published Jun 20, 2025. Retrieved May 10, 2026. Cited by 1 Claim.
- E11MDT executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E12board_seats. board seats. Cited by 31 Claims.
- E13Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Brett Wall executive of Medtronic, effective 2025-06-20.
- Geoffrey S. Martha executive of Medtronic, effective 2025-06-20.
- Gregory L. Smith executive of Medtronic, effective 2025-06-20.
- Ivan K. Fong executive of Medtronic, effective 2025-06-20.
- Matthew Walter executive of Medtronic, effective 2025-06-20.
- Michael Marinaro executive of Medtronic, effective 2025-06-20.
- Skip Kiil executive of Medtronic, effective 2025-06-20.
- John P. Groetelaars seat on Medtronic, effective 2025-01-01.
- Joon S. Lee seat on Medtronic, effective 2025-01-01.
- William R. Jellison seat on Medtronic, effective 2025-01-01.
- Compensation and Talent; Quality committee of Medtronic, effective 2025-01-01.
- Joon S. Lee member of Compensation and Talent; Quality, effective 2025-01-01.
- Growth; Nominating and Corporate Governance committee of Medtronic, effective 2025-01-01.
- John P. Groetelaars member of Growth; Nominating and Corporate Governance, effective 2025-01-01.
- William R. Jellison member of Growth; Operations, effective 2025-01-01.
- Gregory P. Lewis seat on Medtronic, effective 2023-01-01.
- Audit · Chair; Growth committee of Medtronic, effective 2023-01-01.
- Gregory P. Lewis member of Audit · Chair; Growth, effective 2023-01-01.
- Lidia L. Fonseca seat on Medtronic, effective 2022-01-01.
- Audit; Operations; Nominating and Corporate Governance committee of Medtronic, effective 2022-01-01.
- Lidia L. Fonseca member of Audit; Operations; Nominating and Corporate Governance, effective 2022-01-01.
- Kevin E. Lofton seat on Medtronic, effective 2020-01-01.
- Kevin E. Lofton member of Compensation and Talent; Quality, effective 2020-01-01.
- Geoffrey S. Martha seat on Medtronic, effective 2019-01-01.
- Growth; Operations committee of Medtronic, effective 2019-01-01.
- Geoffrey S. Martha member of Growth; Operations, effective 2019-01-01.
- Craig Arnold seat on Medtronic, effective 2015-01-01.
- Randall J. Hogan, III seat on Medtronic, effective 2015-01-01.
- Audit; Operations committee of Medtronic, effective 2015-01-01.
- Randall J. Hogan, III member of Audit; Operations, effective 2015-01-01.
- Growth; Nominating and Corporate Governance · Chair committee of Medtronic, effective 2015-01-01.
- Craig Arnold member of Growth; Nominating and Corporate Governance · Chair, effective 2015-01-01.
- Elizabeth G. Nabel seat on Medtronic, effective 2014-01-01.
- Compensation and Talent · Chair; Growth committee of Medtronic, effective 2014-01-01.
- Elizabeth G. Nabel member of Compensation and Talent · Chair; Growth, effective 2014-01-01.
- Shaun Donnelly seat on Medtronic, effective 2013-01-01.
- Shaun Donnelly member of Audit; Operations, effective 2013-01-01.
- Kendall J. Powell seat on Medtronic, effective 2007-01-01.
- Kendall J. Powell member of Compensation and Talent; Quality, effective 2007-01-01.